The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
- PMID: 28264715
- PMCID: PMC5340010
- DOI: 10.1186/s13643-017-0449-z
The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
Abstract
Background: Atrial fibrillation is the most common arrhythmia of the heart with a prevalence of approximately 2% in the western world. Atrial flutter, another arrhythmia, occurs less often with an incidence of approximately 200,000 new patients per year in the USA. Patients with atrial fibrillation and atrial flutter have an increased risk of death and morbidities. The management of atrial fibrillation and atrial flutter is often based on interventions aiming at either a rhythm control strategy or a rate control strategy. The evidence on the comparable effects of these strategies is unclear. This protocol for a systematic review aims at identifying the best overall treatment strategy for atrial fibrillation and atrial flutter.
Methods: This protocol for a systematic review was performed following the recommendations of the Cochrane Collaboration and the eight-step assessment procedure suggested by Jakobsen and colleagues. We plan to include all relevant randomised clinical trials assessing the effects of any rhythm control strategy versus any rate control strategy. We plan to search the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, LILACS, Science Citation Index Expanded on Web of Science, and BIOSIS to identify relevant trials. Any eligible trial will be assessed and classified as either high risk of bias or low risk of bias, and our conclusions will be based on trials with low risk of bias. The analyses of the extracted data will be performed using Review Manager 5 and Trial Sequential Analysis. For both our primary and secondary outcomes, we will create a 'Summary of Findings' table and use GRADE assessment to assess the quality of the evidence.
Discussion: The results of this systematic review have the potential to benefit thousands of patients worldwide as well as healthcare systems and healthcare economy.
Systematic review registration: PROSPERO CRD42016051433.
Keywords: Atrial fibrillation; Atrial flutter; Meta-analysis; Rate control; Rhythm control; Systematic review; Trial Sequential Analysis.
Similar articles
-
Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Syst Rev. 2017 Apr 5;6(1):71. doi: 10.1186/s13643-017-0470-2. Syst Rev. 2017. PMID: 28381269 Free PMC article.
-
Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.Syst Rev. 2019 Feb 1;8(1):39. doi: 10.1186/s13643-019-0957-0. Syst Rev. 2019. PMID: 30709418 Free PMC article.
-
The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.Syst Rev. 2019 Oct 31;8(1):251. doi: 10.1186/s13643-019-1173-7. Syst Rev. 2019. PMID: 31672170 Free PMC article.
-
Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials.Clin Res Cardiol. 2024 Jun;113(6):831-841. doi: 10.1007/s00392-023-02295-0. Epub 2023 Sep 1. Clin Res Cardiol. 2024. PMID: 37658166 Free PMC article.
-
Pharmacological therapy in children with atrial fibrillation and atrial flutter.Curr Pharm Des. 2008;14(8):770-5. doi: 10.2174/138161208784007707. Curr Pharm Des. 2008. PMID: 18393877 Review.
Cited by
-
Health apps targeting children with overweight-a protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.Syst Rev. 2020 Feb 11;9(1):28. doi: 10.1186/s13643-020-1269-0. Syst Rev. 2020. PMID: 32046781 Free PMC article.
-
The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.PLoS One. 2017 Oct 26;12(10):e0186856. doi: 10.1371/journal.pone.0186856. eCollection 2017. PLoS One. 2017. PMID: 29073191 Free PMC article.
-
Psychotherapy versus treatment as usual and other control interventions in children and adolescents with overweight and obesity: a protocol for systematic review with meta-analysis and Trial Sequential Analysis.BMJ Open. 2020 Nov 5;10(11):e036058. doi: 10.1136/bmjopen-2019-036058. BMJ Open. 2020. PMID: 33154043 Free PMC article.
References
-
- Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace. 2012;14(10):1385–1413. doi: 10.1093/europace/eus305. - DOI - PubMed
-
- Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847. doi: 10.1161/CIRCULATIONAHA.113.005119. - DOI - PMC - PubMed
-
- Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, Raftery JP, Bryan S, Davies M, Lip GY, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335(7616):383. doi: 10.1136/bmj.39280.660567.55. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical